Novo Nordisk A S (NONOF) stock

NONOFOTCPharmaceutical PreparationsFiscal year ends December 31Also trades as NVO

Financials through fiscal 2025, year ended Dec 31, 2025Score 4/30

$38.24−0.60 (-1.53%)

Close on Oct 19, 2026Market cap $170.76BP/E 11.1Yield –

Novo Nordisk A S gross margin

Gross margin is gross profit as a percentage of revenue.

For fiscal 2025 it was 81.0%, against 84.7% the year before. The highest annual figure on record is 85.0% in fiscal 2015.

Period	Period end	Value	Change (pts)
FY2025	Dec 31, 2025	81.0%	−3.7
FY2024	Dec 31, 2024	84.7%	+0.1
FY2023	Dec 31, 2023	84.6%	+0.7
FY2022	Dec 31, 2022	83.9%	+0.7
FY2021	Dec 31, 2021	83.2%	−0.3
FY2020	Dec 31, 2020	83.5%	−0.0
FY2019	Dec 31, 2019	83.5%	−0.7
FY2018	Dec 31, 2018	84.2%	+0.0
FY2017	Dec 31, 2017	84.2%	−0.4
FY2016	Dec 31, 2016	84.6%	−0.4
FY2015	Dec 31, 2015	85.0%	–

Parsed from the XBRL in Novo Nordisk A S's annual and quarterly filings with the SEC
Per-share figures adjusted for the 2-for-1 split on Jan 31, 2024
Fourth quarters derived from the annual report minus nine months
Every figure in the statements links to its source filing

Trailing twelve months. Peers are matched on business description, industry and size. Ticks are peers, the dot is NONOF.

Revenue growth6.4% · median 8.9%

Gross margin81.0% · median 69.7%

Advertisement
300 × 250

See a number that looks wrong?